Terms: = Prostate cancer AND GOPC, FIG, 57120, ENSG00000047932, GOPC1, Q9HD26, CAL, dJ94G16_2 PIST AND Treatment
29 results:
1. Short-term autophagy inhibition by autophinib or SAR405 does not alter the effect of cisplatin on ATP production in prostate cancer cells.
Kratochvilova M; Stepka P; Raudenska M; Balvan J; Richtera L; Cernei N; Skopalova DS; Zitka O; Filipensky P; Babula P; Masarik M
Bratisl Lek Listy; 2024; 124(2):84-91. PubMed ID: 38219060
[TBL] [Abstract] [Full Text] [Related]
2. Increased ROS alters E-/N-cadherin levels and promotes migration in prostate cancer cells.
Varisli L; Tolan V
Bratisl Lek Listy; 2022; 123(10):752-757. PubMed ID: 35913012
[TBL] [Abstract] [Full Text] [Related]
3. New perspectives of quercetin and vitamin C effects on fibronectin-binding integrins and chemokine receptors in prostate cancer cell lines.
Amiri A; Abbasi A; Dehghani M; Ramezani A; Ramezani F; Zal F; Mostafavi-Pour Z
Bratisl Lek Listy; 2021; 122(7):507-512. PubMed ID: 34161119
[TBL] [Abstract] [Full Text] [Related]
4. New treatment Strategy Targeting Galectin-1 against Thyroid cancer.
Gheysen L; Soumoy L; Trelcat A; Verset L; Journe F; Saussez S
Cells; 2021 May; 10(5):. PubMed ID: 34063063
[TBL] [Abstract] [Full Text] [Related]
5. Novel ANO1 Inhibitor from
Seo Y; Anh NH; Heo Y; Park SH; Kiem PV; Lee Y; Yen DTH; Jo S; Jeon D; Tai BH; Nam NH; Minh CV; Kim SH; Nhiem NX; Namkung W
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899792
[TBL] [Abstract] [Full Text] [Related]
6. Chrysosplenol d, a Flavonol from
Lang SJ; Schmiech M; Hafner S; Paetz C; Werner K; El Gaafary M; Schmidt CQ; Syrovets T; Simmet T
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521698
[TBL] [Abstract] [Full Text] [Related]
7. Investigation of lncRNA H19 in prostate cancer cells and secreted exosomes upon androgen stimulation or androgen receptor blockage.
Ozgur E; Gezer U
Bratisl Lek Listy; 2020; 121(5):362-365. PubMed ID: 32356434
[TBL] [Abstract] [Full Text] [Related]
8. Extremely rare synchronous primary neoplasms in testicular cancer patients.
Mrinakova B; Ondrusova M; Lehotska V; Ondrus D
Bratisl Lek Listy; 2019; 120(9):641-645. PubMed ID: 31475546
[TBL] [Abstract] [Full Text] [Related]
9. New principles of cancer therapy give new hope for oncological patients.
Bernadic M; Duchon R; Aziri R; Mladosievicova B
Bratisl Lek Listy; 2019; 120(1):15-18. PubMed ID: 30685987
[TBL] [Abstract] [Full Text] [Related]
10. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.
Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M
J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577
[TBL] [Abstract] [Full Text] [Related]
11. Structure and function of FUS gene in prostate cancer.
Ghanbarpanah E; Kohanpour MA; Hosseini-Beheshti F; Yari L; Keshvari M
Bratisl Lek Listy; 2018; 119(10):660-663. PubMed ID: 30345776
[TBL] [Abstract] [Full Text] [Related]
12. Results of long term testosterone replacement therapy in men with abdominal obesity, erectile dysfunction and testosterone deficiency.
Fillo J; Breza J; Ondrusova M; Luha J; Ondrus D; Dubravicky J; Breza J; Labas P; Levcikova M
Bratisl Lek Listy; 2018; 119(9):577-580. PubMed ID: 30226069
[TBL] [Abstract] [Full Text] [Related]
13. Antiproliferative and antiapoptotic effect of thymoquinone on cancer cells in vitro.
Kus G; Ozkurt M; Kabadere S; Erkasap N; Goger G; Demirci F
Bratisl Lek Listy; 2018; 119(5):312-316. PubMed ID: 29749248
[TBL] [Abstract] [Full Text] [Related]
14. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
[TBL] [Abstract] [Full Text] [Related]
15. Phthalate induced toxicity in prostate cancer cell lines and effects of alpha lipoic acid.
Kismali G; Yurdakok-Dikmen B; Kuzukiran O; Arslan P; Filazi A
Bratisl Lek Listy; 2017; 118(8):460-466. PubMed ID: 29050483
[TBL] [Abstract] [Full Text] [Related]
16. [Urinary disturbance in elder patients -Characteristic and problems based on the sex-].
Fukumori T
Nihon Rinsho; 2017 Apr; 75(4):553-557. PubMed ID: 30549856
[TBL] [Abstract] [Full Text] [Related]
17. Step-by-Step Technique for Irreversible Electroporation of Focal prostate cancer: An Instructional Video Guide.
Ting F; Van Leeuwen PJ; Stricker PD
J Vasc Interv Radiol; 2016 Apr; 27(4):568. PubMed ID: 27013005
[TBL] [Abstract] [Full Text] [Related]
18. Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients.
Buonerba C; Federico P; D'Aniello C; Rescigno P; Cavaliere C; Puglia L; Ferro M; Altieri V; Perdonà S; De Placido S; Di Lorenzo G
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1455-61. PubMed ID: 21365219
[TBL] [Abstract] [Full Text] [Related]
19. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Ramirez E; Heuze Y; Flores E
Curr Med Chem; 2005; 12(8):927-43. PubMed ID: 15853706
[TBL] [Abstract] [Full Text] [Related]
20. Decreased survival of prostate cancer cells in vitro by combined treatment of heat and an antioxidant inhibitor diethyldithiocarbamate (DDC).
Moriyama-Gonda N; Igawa M; Shiina H; Urakami S; Terashima M
Exp Toxicol Pathol; 2003 Nov; 55(4):251-6. PubMed ID: 14703770
[TBL] [Abstract] [Full Text] [Related]
[Next]
